Only a small proportion of Sydney’s population were infected by SARS-CoV-2 earlier this year, a new report co-led by UNSW’s Kirby Institute says.
A clinical trial across 12 countries will test a potential COVID-19 treatment, using antibodies purified from plasma taken from people who have recovered from the disease.
Professor John Whitelock is improving the smarts of antibodies and sending them into the extracellular area to outwit those clever cancer cells.
